Nasal High-Flow in COPD

NARecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2025

Study Completion Date

December 30, 2025

Conditions
COPD Exacerbation
Interventions
DEVICE

Nasal High Flow Therapy

Nasal High Flow Therapy (nHFT) is an innovative therapy for patients with respiratory diseases. It supplies heated, humidified, and oxygen-enriched air at high flow rates through a nasal cannula. Because the air is provided through an open system with a nasal cannula, it is relatively easy to apply and suggested to be very comfortable for patients. The technique has been shown to be effective in the treatment of hypoxemic respiratory failure, mainly in neonates\[2\] and patients with acute hypoxemic respiratory failure on intensive care units (ICU).\[3\]

OTHER

Standard care

Standard regular care of a COPD exacerbation

Trial Locations (3)

Unknown

RECRUITING

Rijnstate Hospital, Arnhem

RECRUITING

Albert Schweizer ziekenhuis, Dordrecht

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

All Listed Sponsors
collaborator

Rijnstate Hospital

OTHER

collaborator

Medisch Spectrum Twente

OTHER

collaborator

Albert Schweitzer Hospital

OTHER

collaborator

Technical University of Twente

OTHER

collaborator

Fisher and Paykel Healthcare

INDUSTRY

collaborator

Vivisol

OTHER

lead

Marieke Duiverman

OTHER